When Should Osteosarcoma Dogs Get Chemotherapy After Amputation?
When should an osteosarcoma dog get chemotherapy? Here’s what the latest research shows about timing and survival rates.
chemotherapy
How Combination Chemotherapy Manages Mets
Learn how combination chemotherapy helps senior dog Jake beat the osteosarcoma odds with monthly carboplatin and Palladia doses.
Torigen Immunotherapy Vaccine: Hope for Pets with Cancer Podcast
If your Tripawd has cancer, learn how the Torigen immunotherapy vaccine can give your dog or cat the best chance at fighting the disease.
Tripawd Tuesday: Lance, a Greyhound Cancer Fighter Therapy Dog Hero!
Meet an incredible Greyhound cancer fighting hero, Lance the therapy dog we are celebrating in today’s Tripawd Tuesday feature!
Three Tripawds’ Inhalation Chemotherapy Treatment Stories (Updated 2023)
If your Tripawd has lung metastasis, you may want to investigate inhalation chemotherapy treatment options to fight the spread of pulmonary metastasis.
UC Davis Inhalation Chemotherapy Study for Dogs Fights Lung Metastasis
There’s new hope for dogs with advanced osteosarcoma lung metastasis, thanks to a new UC Davis Inhalation Chemotherapy Study for Dogs.
Local Intralesional Chemotherapy Treatment for Pet Cancer
If your Tripawd has a remaining limb tumor, here’s why you need to ask your vet oncologist about local intralesional chemotherapy.
Electrochemotherapy Pet Cancer Questions and Answers
Get your electrochemotherapy pet cancer questions answered in part two of our interview with ECT expert Dr. Jeannette Kelly of Santa Fe Vet Cancer Care.
The Electrochemotherapy Pet Cancer Treatment Option – Updated 2022
Vet oncologist Dr. Jeanette Kelly explains how the electrochemotherapy pet cancer treatment option can shrink soft tissue skin tumors in dogs and cats.
Tripawd Chemotherapy Candidates and Alternatives
Pet cancer treatments are not one-size-fits-all and today you’ll learn which Tripawd chemotherapy candidates are ideal, as well as chemotherapy alternatives for those who aren’t, with Dr. Bernard Seguin from the Flint Animal Cancer Center at Colorado State University.